{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:02:15Z","timestamp":1791302535989,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.intimp.2024.112409","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T17:22:22Z","timestamp":1717780942000},"page":"112409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Iguratimod ameliorates antibody-mediated rejection after renal transplant by modulating the Th17\/Treg paradigm"],"prefix":"10.1016","volume":"136","author":[{"given":"Hongcheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyun","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baixin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1054-9200","authenticated-orcid":false,"given":"Zijie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.112409_b0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1186\/s12882-023-03401-0","article-title":"Proteomic analysis investigating kidney transplantation outcomes \u2013 a scoping review","volume":"24","author":"Rainey","year":"2023","journal-title":"BMC Nephrol."},{"issue":"Suppl 2","key":"10.1016\/j.intimp.2024.112409_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16982","article-title":"OPTN\/SRTR 2020 annual data report: kidney","volume":"22","author":"Lentine","year":"2022","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.intimp.2024.112409_b0015","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study","volume":"17","author":"Halloran","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.intimp.2024.112409_b0020","first-page":"853","article-title":"Long-term renal allograft survival: a quiet revolution","volume":"94","author":"Jardine","year":"2018","journal-title":"KidneyInt"},{"issue":"1","key":"10.1016\/j.intimp.2024.112409_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MNH.0000000000000843","article-title":"Updated management for antibody-mediated rejection: opportunity to prolong kidney allograft survival","volume":"32","author":"Townamchai","year":"2023","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.intimp.2024.112409_b0030","doi-asserted-by":"crossref","first-page":"6872046","DOI":"10.1155\/2017\/6872046","article-title":"Treatment of antibody-mediated renal allograft rejection: improving step by step","volume":"2017","author":"Lachmann","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.112409_b0035","unstructured":"R.H. Naik, S.H. Shawar, Renal Transplantation Rejection, StatPearls, StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC., Treasure Island (FL) ineligible companies. Disclosure: Saed Shawar declares no relevant financial relationships with ineligible companies, 2023."},{"issue":"1","key":"10.1016\/j.intimp.2024.112409_b0040","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-065X.2010.00951.x","article-title":"Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors","volume":"238","author":"Zhu","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.112409_b0045","first-page":"91","article-title":"CD4(+) T-cell differentiation in vitro","volume":"2111","author":"Yang","year":"2020","journal-title":"MethodsMol Biol"},{"issue":"3","key":"10.1016\/j.intimp.2024.112409_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030730","article-title":"The balance of Th17 versus Treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.112409_b0055","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3389\/fimmu.2020.01027","article-title":"T Cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus","volume":"11","author":"Shan","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112409_b0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","article-title":"The pathogenicity of Th17 cells in autoimmune diseases","volume":"41","author":"Yasuda","year":"2019","journal-title":"Semin. Immunopathol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112409_b0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"10.1016\/j.intimp.2024.112409_b0070","first-page":"423","article-title":"The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus","volume":"14","author":"Wang","year":"2017","journal-title":"CellMol Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.112409_b0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cyto.2012.03.018","article-title":"Th17 cell-derived IL-17 is dispensable for B cell antibody production","volume":"59","author":"Shibui","year":"2012","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2024.112409_b0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ni1552","article-title":"Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice","volume":"9","author":"Hsu","year":"2008","journal-title":"Nat. Immunol."},{"issue":"32","key":"10.1016\/j.intimp.2024.112409_b0085","doi-asserted-by":"crossref","first-page":"14292","DOI":"10.1073\/pnas.1009234107","article-title":"Proinflammatory T helper type 17 cells are effective B-cell helpers","volume":"107","author":"Mitsdoerffer","year":"2010","journal-title":"PNAS"},{"issue":"7","key":"10.1016\/j.intimp.2024.112409_b0090","first-page":"945","article-title":"Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4'-1-benzopyran-4-o ne. 2nd communication: effect on the arachidonic acid cascades","volume":"42","author":"Tanaka","year":"1992","journal-title":"Arzneimittelforschung"},{"issue":"7559","key":"10.1016\/j.intimp.2024.112409_b0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.intimp.2024.112409_b0100","doi-asserted-by":"crossref","first-page":"e14565","DOI":"10.1111\/ctr.14565","article-title":"Iguratimod reduces panel reactive antibody in high mismatched renal transplant recipients: One single-center experience","volume":"36","author":"Feng","year":"2022","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.intimp.2024.112409_b0105","doi-asserted-by":"crossref","unstructured":"A. Loupy, M. Haas, C. Roufosse, M. Naesens, B. Adam, M. Afrouzian, E. Akalin, N. Alachkar, S. Bagnasco, J.U. Becker, L.D. Cornell, M.C. Clahsen-van Groningen, A.J. Demetris, D. Dragun, J.P. Duong van Huyen, A.B. Farris, A.B. Fogo, I.W. Gibson, D. Glotz, J. Gueguen, Z. Kikic, N. Kozakowski, E. Kraus, C. Lefaucheur, H. Liapis, R.B. Mannon, R.A. Montgomery, B.J. Nankivell, V. Nickeleit, P. Nickerson, M. Rabant, L. Racusen, P. Randhawa, B. Robin, I.A. Rosales, R. Sapir-Pichhadze, C.A. Schinstock, D. Seron, H.K. Singh, R.N. Smith, M.D. Stegall, A. Zeevi, K. Solez, R.B. Colvin, M. Mengel, The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection, Am. J. Transplant 20(9) (2020) 2318-2331.","DOI":"10.1111\/ajt.15898"},{"issue":"26","key":"10.1016\/j.intimp.2024.112409_b0110","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr. Pharm. Des."},{"issue":"7829","key":"10.1016\/j.intimp.2024.112409_b0115","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2799-2","article-title":"A STAT3 palmitoylation cycle promotes T(H)17 differentiation and colitis","volume":"586","author":"Zhang","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2024.112409_b0120","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/ajt.14228","article-title":"Assessment of tocilizumab (anti-interleukin-6 receptor monoclonal) as a potential treatment for chronic antibody-mediated rejection and transplant glomerulopathy in HLA-sensitized renal allograft recipients","volume":"17","author":"Choi","year":"2017","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.intimp.2024.112409_b0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/TP.0000000000002049","article-title":"The treatment of antibody-mediated rejection in kidney transplantation: an updated systematic review and meta-analysis","volume":"102","author":"Wan","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2024.112409_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.865363","article-title":"Iguratimod attenuates macrophage polarization and antibody-mediated rejection after renal transplant by regulating KLF4","volume":"13","author":"Hang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112409_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.738392","article-title":"Efficacy and safety of iguratimod supplement to the standard immunosuppressive regimen in highly mismatched renal transplant recipients: a pilot study","volume":"12","author":"Tao","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2024.112409_b0140","first-page":"1002","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"CellMol Immunol"},{"issue":"9","key":"10.1016\/j.intimp.2024.112409_b0145","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/eji.202048794","article-title":"Transcriptional and posttranslational regulation of Th17\/Treg balance in health and disease","volume":"51","author":"Zhang","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112409_b0150","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.transproceed.2009.01.092","article-title":"Interleukin-17 and kidney allograft outcome","volume":"41","author":"Crispim","year":"2009","journal-title":"Transpl. Proc."},{"issue":"2","key":"10.1016\/j.intimp.2024.112409_b0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2009.08.001","article-title":"Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity","volume":"31","author":"Sutton","year":"2009","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.intimp.2024.112409_b0160","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/imt-2020-0071","article-title":"Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis","volume":"12","author":"Zavvar","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.intimp.2024.112409_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.746889","article-title":"Utilization of Treg cells in solid organ transplantation","volume":"13","author":"Juneja","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112409_b0170","first-page":"1003","article-title":"Concomitant loss of regulatory T and B cells is a distinguishing immune feature of antibody-mediated rejection in kidney transplantation","volume":"101","author":"Louis","year":"2022","journal-title":"KidneyInt"},{"key":"10.1016\/j.intimp.2024.112409_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107563","article-title":"Iguratimod ameliorates nephritis by modulating the Th17\/Treg paradigm in pristane-induced lupus","volume":"96","author":"Xia","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112409_b0180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molimm.2017.10.008","article-title":"Iguratimod ameliorates inflammatory responses by modulating the Th17\/Treg paradigm in dextran sulphate sodium-induced murine colitis","volume":"93","author":"Jiang","year":"2018","journal-title":"Mol. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112409_b0185","first-page":"1676","article-title":"Effect of combined application of iguratimod in the treatment of active rheumatoid arthritis on bone metabolism, Th17 cells and Treg cells","volume":"13","author":"Wen","year":"2021","journal-title":"Am. J. Transl. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924009299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:43:35Z","timestamp":1791301415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924009299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S1567576924009299"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112409","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iguratimod ameliorates antibody-mediated rejection after renal transplant by modulating the Th17\/Treg paradigm","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112409"}}